Advertisement
Screener

COMPASS THERAPEUTICS, INC. (CMPX) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

COMPASS THERAPEUTICS, INC. Cash Flow Breakdown

Cash flow breakdown shows where COMPASS THERAPEUTICS, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2026-03-31: from running the business, $53.20M went out.
  • Fiscal year ended 2026-03-31: from investing, $66.47M went out.
  • Fiscal year ended 2026-03-31: from financing, $133.79M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backStaff share taxNew shares soldNot split outChange in cash
2026-03-31-$53.20M*-$66.47M*-$701.00K*$134.49M*
2025-12-31-$49.14M-$93.31M-$1.03M$138.00M-$7.36M*-$12.84M
2025-03-31-$44.17M*$62.46M*-$911.00K*$0.00*
2024-12-31-$44.85M$46.77M-$232.00K$18.11M-$543.00K*$19.25M
2024-03-31-$42.28M*$18.60M*-$295.00K*$21.24M*-$617.00K*
2023-12-31-$40.62M$26.96M-$159.00K$3.13M-$10.72M
2023-03-31-$38.41M*-$146.74M*$56.00K*$75.74M*
2022-12-31-$34.13M-$151.20M$0.00$0.00$76.24M-$109.57M
2022-03-31-$22.00M*-$1.95M*-$7.50M*$127.99M*
2021-12-31-$19.67M-$1.77M-$9.38M$128.27M$97.17M
2021-03-31-$24.65M*$37.00K*
2020-12-31-$26.80M$38.00K-$5.63M$60.48M-$6.32M*$21.77M
2020-03-31-$32.11K-$1.12K
2019-12-31-$31.74M-$466.00K-$32.21M
2019-03-31-$32.76K$4.87K

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backNew debtStaff share taxNew shares soldNot split outChange in cash
2026-06-30-$14.74M*-$4.98M*$0.00*$0.00*
2026-03-31-$17.27M$38.43M-$489.00K$3.85M$24.52M
2025-12-31-$13.25M*-$3.38M*-$212.00K*$0.00*$1.27M*
2025-09-30-$10.85M*-$95.16M*$0.00*$138.00M*-$8.64M*
2025-06-30-$11.83M*-$6.36M*$0.00*$0.00*
2025-03-31-$13.21M$11.59M-$815.00K$0.00-$2.44M
2024-12-31-$9.16M*$15.37M*-$96.00K*$0.00*
2024-09-30-$11.05M*$29.02M*$0.00*$0.00*
2024-06-30-$10.75M*$6.48M*$0.00*$0.00*
2024-03-31-$13.89M-$4.10M-$136.00K$18.11M-$544.00K*-$554.00K
2023-12-31-$12.35M*$6.31M*-$159.00K*$0.00*
2023-09-30-$5.92M*$17.05M*$0.00*$0.00*
2023-06-30-$10.11M*-$667.00K*$0.00*$3.13M*
2023-03-31-$12.23M$4.27M$0.00$0.00-$7.92M
2022-12-31-$10.64M*-$46.65M*$0.00*$76.24M*
2022-09-30-$10.94M*$1.18M*$0.00*$0.00*
2022-06-30-$4.60M*-$105.54M*$0.00*$0.00*
2022-03-31-$7.94M-$193.00K$0.00$0.00-$8.13M
2021-12-31-$4.67M*-$776.00K*-$3.75M*$128.27M*
2021-09-30-$3.46M*-$367.00K*-$1.88M*$0.00*$0.00*
2021-06-30-$5.94M*-$614.00K*-$1.88M*$0.00*
2021-06-20-$5.94M*-$614.00K*-$1.88M*
2021-03-31-$5.61M-$13.00K-$1.88M-$7.49M
2020-12-31-$6.57M*$6.00K*-$1.88M*$0.00*
2020-09-30-$7.17M*-$7.00K*-$1.88M*$0.00*-$802.00K*
2020-06-30-$5.30M*$51.00K*
2020-03-31-$7.76M-$12.00K-$7.77M
2019-12-31-$7.24K*-$185.00K*$262.00*
2019-09-30-$6.70M*-$27.00K*
2019-03-31-$9.81K*$187.00*
2018-12-31-$10.27K*$2.23K*
2018-09-30-$4.79K*-$4.79K*
2018-06-30-$7.89K$7.23K

Similar stocks

Stock NameCountryMarket CapPE Ratio
Protara Therapeutics, Inc. (TARA)United States$0.198B-3.22
Alector, Inc. (ALEC)United States$0.213B-1.90
ANAVEX LIFE SCIENCES CORP. (AVXL)United States$0.218B-18.37
Protalix BioTherapeutics, Inc. (PLX)$0.221B9.87
Alpha Cognition Inc. (ACOG)$0.185B-6.77
Coherus Oncology, Inc. (CHRS)United States$0.182B-1.63
PRECISION BIOSCIENCES INC (DTIL)United States$0.175B-3.95
Voyager Therapeutics, Inc. (VYGR)United States$0.173B-1.99
Aligos Therapeutics, Inc. (ALGS)United States$0.238B-0.47
Lineage Cell Therapeutics, Inc. (LCTX)United States$0.241B-10.35